Skip to main content
. Author manuscript; available in PMC: 2019 Nov 27.
Published in final edited form as: Ann Intern Med. 2009 Apr 7;150(7):474–484. doi: 10.7326/0003-4819-150-7-200904070-00007

Figure. Study flow diagram.

Figure.

CVD cardiovascular disease; NMR nuclear magnetic resonance.

* Description of methods used to measure low-density lipoprotein (LDL) subfractions, comparison of different methods, variability of measures, link between therapies to alter LDL subfractions and CVD outcomes, and association between LDL subfractions and incident and prevalent CVD.

† No clinical CVD outcome, not LDL subfractions, not an analysis of baseline lipoprotein subfractions, or no original data.

HHS Vulnerability Disclosure